跳至主要内容
临床试验/IRCT20201023049126N1
IRCT20201023049126N1招募中3 期

Assess the effectiveness of Sodium valproate on level of albuminuria in patient with type 2 diabetes :A double-blind randomized clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • patients with DMTII
  • albuminuria more than 30mg/dl

排除标准

  • Allergy to valproic acid
  • Significantly abnormal liver function test
  • A history of known mental disorders
  • History of cardiac or liver diseases
  • Females who were lactating, pregnant, or intending to become pregnant during the study.
  • A current history of alcohol addiction or drug abuse including analgesics
  • abnormal blood cells counts
  • eGFR less than 60 ml/min/1.73m2
  • hemoglobin A1c more than 8
  • Blood Pressure more than 160/100 mmHg
  • neurologic disease such as seizure
  • use antidepressant or antipsychotic drugs
  • History of GN, renal stone or other renal disease that induced proteinuria
  • active hematologic, rheumatologic or infectious diseases
  • active cancers or tumors
  • uncontrol hypo or hyper thyroidism
  • uncontrol hyper parathyroidism

研究者

相似试验

Sodium Valproate and Diabetic nephropathy | 临床试验